A tumor-binding antibody with cross-reactivity to viral antigens
Abstract Background We previously identified in non-small cell lung cancer (NSCLC) patients an autoantibody to complement factor H (CFH) that is associated with non-metastatic disease and longer time to progression in patients with stage I disease. A recombinant human antibody, GT103, was cloned fro...
Saved in:
| Main Authors: | Michael J. Campa, Elizabeth B. Gottlin, Kevin Wiehe, Edward F. Patz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-02-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-03975-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibodies directed against bacterial antigens in sera of Polish patients with primary biliary cholangitis
by: Alicja Bauer, et al.
Published: (2025-01-01) -
Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230
by: Feliciana Mariotti, et al.
Published: (2024-11-01) -
Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation
by: Jesper Karlsson, et al.
Published: (2025-05-01) -
Case report: anti-fibrillarin autoantibodies induced by viral molecular mimicry in a paediatric patient
by: Chiara Autilio, et al.
Published: (2025-07-01) -
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold
by: Tiphanie Pruvost, et al.
Published: (2023-12-01)